09:38 AM EST, 01/13/2025 (MT Newswires) -- Rigel Pharmaceuticals ( RIGL ) said Monday it expects Q4 total revenue of $57.6 million, up from $35.8 million a year earlier.

Analysts polled by FactSet expect $47.4 million.

The company also said it expects 2025 total revenue of about $200 million to $210 million. Analysts surveyed by FactSet expect $193.5 million.

Rigel said it expects to report cash, cash equivalents and short-term investments of about $77.3 million as of Dec. 31, 2024.

The company said it plans to release complete results for Q4 and full-year 2024 in March.

Shares were up 2.2% in recent Monday trading.

Price: 16.61, Change: +0.36, Percent Change: +2.22